Genetic Evaluation of Beef Sires Using a Beef‐on‐Dairy Crossbred Reference Population
Journal of Animal Breeding and Genetics · 2026-05 · 143 (3) · 390-402
DOI: 10.1111/jbg.70030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Animal Breeding and Genetics, online erschienen am 15.11.2025. Verfasst von Julius Mugambe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biosciences, SLU, Interbull Centre, Uppsala, Sweden. Hauptthemen laut MEDLINE: Breeding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Food and Agriculture.
Abstract (Originalsprache)
In recent years, Beef‐on‐Dairy (BoD) crossbreeding programs have gained momentum to enhance dairy cattle's economic and genetic merits while meeting the demand for high‐quality beef. However, bulls with superior growth potential can lead to calving problems; thus, Holstein dairy farmers must decide which semen to use to avoid calving problems while producing heavier BoD calves. In this study, our objective was to genetically evaluate beef sires using a BoD crossbred reference population for three major economic traits, i.e., gestation length (GL), birth weight (BW), and calving ease (CE). A population comprising 4420 BoD calves sired by bulls from Angus (ANG), Limousin (LIM), Wagyu (WAG), and White‐Belgian Blue (WBB) was used to perform a joint genetic evaluation of the sire for traits. Univariate and bivariate (linear‐linear or threshold‐linear) models were applied to estimate variance components and genomic breeding values using single‐step methods. Estimates from CE models were transformed from the liability to the observable scale for more straightforward interpretation. Direct heritabilities for GL, BW, and CE (after transformations) ranged from 0.33 to 0.35, 0.33 to 0.37, and 0.02 to 0.14, respectively, while maternal heritabilities ranged from 0.11 to 0.17 for all traits. Generally, male BoD calves had higher probabilities for calving difficulty, with calvings being more difficult if sired by LIM (13%) as compared to ANG (7%) and WBB (9%) when considering male calves. The bivariate models outperformed the univariate models. For CE, the accuracy of predictions was up by 95% with a reduction in bias and dispersion. WBB sires were preferred when crossing with higher parity cows compared to ANG sires. These findings demonstrate that a well‐structured BoD reference population enables accurate genomic evaluation of beef sires, facilitating the selection of sires that produce economically viable calves with reduced calving difficulties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Biosciences, SLU, Interbull Centre, Uppsala, Sweden.
- Institut für Tierzucht Und Tierhaltung, Christian-Albrechts-Universität Zu Kiel, Kiel, Germany.
- IT-Solutions for Animal Production (Vit), Verden, Germany.
- Department of Animal and Dairy Science, University of Georgia, Athens, Georgia, USA.
ORCID-Profile: Julius Mugambe, Jorge Hidalgo
Förderung
- German Federal Ministry of Food and Agriculture
Zitieren
APA
Mugambe, J., Schmidtmann, C., Hidalgo, J., Ahmed, R., & Thaller, G. (2026). Genetic Evaluation of Beef Sires Using a Beef‐on‐Dairy Crossbred Reference Population. Journal of Animal Breeding and Genetics, 143(3), 390-402. https://doi.org/10.1111/jbg.70030
Vancouver
Mugambe J, Schmidtmann C, Hidalgo J, Ahmed R, Thaller G. Genetic Evaluation of Beef Sires Using a Beef‐on‐Dairy Crossbred Reference Population. Journal of Animal Breeding and Genetics. 2026;143(3):390-402. doi:10.1111/jbg.70030
BibTeX
@article{Mugambe2026,
author = {Mugambe, Julius and Schmidtmann, Christin and Hidalgo, Jorge and Ahmed, Rana and Thaller, Georg},
title = {Genetic Evaluation of Beef Sires Using a Beef‐on‐Dairy Crossbred Reference Population},
journal = {Journal of Animal Breeding and Genetics},
year = {2026},
volume = {143},
number = {3},
pages = {390--402},
doi = {10.1111/jbg.70030}
}
EUVIMED